The purpose of the trial is to establish the safety and effectiveness of the Edwards Sapien 3 / Sapien 3 Ultra transcatheter heart valve in moderate, calcific aortic stenosis; S3 and S3 Ultra are established technologies in severe aortic stenosis.
Please use this link for further information:
Primary Investigator: Dean Kereiakes